{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:29:28Z","timestamp":1782840568048,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,6,11]]},"DOI":"10.1038\/s41388-025-03328-w","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T01:00:12Z","timestamp":1741222812000},"page":"1567-1577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A mitochondrial outer membrane protein TOMM20 maintains protein stability of androgen receptor and regulates AR transcriptional activity in prostate cancer cells"],"prefix":"10.1038","volume":"44","author":[{"given":"Linglong","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuli","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"3328_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3328_CR2","doi-asserted-by":"crossref","unstructured":"Aurilio G, Cimadamore A, Mazzucchelli R, Lopez-Beltran A, Verri E, Scarpelli M, et al. Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications. Cells 2020;9:2653.","DOI":"10.3390\/cells9122653"},{"key":"3328_CR3","first-page":"113","volume":"14","author":"G Wilding","year":"1992","unstructured":"Wilding G. The importance of steroid hormones in prostate cancer. Cancer Surv. 1992;14:113\u201330.","journal-title":"Cancer Surv"},{"key":"3328_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835\u20139.","journal-title":"Cell"},{"key":"3328_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1615\/CritRevEukarGeneExpr.v5.i2.10","volume":"5","author":"C Chang","year":"1995","unstructured":"Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, et al. Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr. 1995;5:97\u2013125.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"3328_CR6","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.1074\/jbc.271.45.28697","volume":"271","author":"Y Fang","year":"1996","unstructured":"Fang Y, Fliss AE, Robins DM, Caplan AJ. Hsp90 regulates androgen receptor hormone binding affinity in vivo. J Biol Chem. 1996;271:28697\u2013702.","journal-title":"J Biol Chem"},{"key":"3328_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/1535-7163.MCT-18-0432","volume":"18","author":"J Dong","year":"2019","unstructured":"Dong J, Wu Z, Wang D, Pascal LE, Nelson JB, Wipf P, et al. Hsp70 binds to the androgen receptor N-terminal domain and modulates the receptor function in prostate cancer cells. Mol Cancer Ther. 2019;18:39\u201350.","journal-title":"Mol Cancer Ther"},{"key":"3328_CR8","doi-asserted-by":"publisher","first-page":"11824","DOI":"10.1021\/bi0259150","volume":"41","author":"V Georget","year":"2002","unstructured":"Georget V, Terouanne B, Nicolas JC, Sultan C. Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry. 2002;41:11824\u201331.","journal-title":"Biochemistry"},{"key":"3328_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2004.12.037","volume":"231","author":"J Prescott","year":"2006","unstructured":"Prescott J, Coetzee GA. Molecular chaperones throughout the life cycle of the androgen receptor. Cancer Lett. 2006;231:12\u201319.","journal-title":"Cancer Lett"},{"key":"3328_CR10","first-page":"3","volume":"37","author":"RA Davey","year":"2016","unstructured":"Davey RA, Grossmann M. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37:3\u201315.","journal-title":"Clin Biochem Rev"},{"key":"3328_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrurol.2014.320","volume":"12","author":"AA Azad","year":"2015","unstructured":"Azad AA, Zoubeidi A, Gleave ME, Chi KN. Targeting heat shock proteins in metastatic castration-resistant prostate cancer. Nat Rev Urol. 2015;12:26\u201336.","journal-title":"Nat Rev Urol"},{"key":"3328_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-145","volume":"12","author":"K Grupp","year":"2013","unstructured":"Grupp K, Jedrzejewska K, Tsourlakis MC, Koop C, Wilczak W, Adam M, et al. High mitochondria content is associated with prostate cancer disease progression. Mol Cancer. 2013;12:145.","journal-title":"Mol Cancer"},{"key":"3328_CR13","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s10815-021-02282-2","volume":"38","author":"R Masciangelo","year":"2021","unstructured":"Masciangelo R, Chiti MC, Camboni A, Amorim CA, Donnez J, Dolmans MM. Mitochondrial content, activity, and morphology in prepubertal and adult human ovaries. J Assist Reprod Genet. 2021;38:2581\u201390.","journal-title":"J Assist Reprod Genet"},{"key":"3328_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101870","volume":"298","author":"UMH Sayyed","year":"2022","unstructured":"Sayyed UMH, Mahalakshmi R. Mitochondrial protein translocation machinery: From TOM structural biogenesis to functional regulation. J Biol Chem. 2022;298:101870.","journal-title":"J Biol Chem"},{"key":"3328_CR15","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ejso.2014.04.005","volume":"40","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, Han F, He Y, Yang S, Hua L, Wu J, et al. Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors. Eur J Surg Oncol. 2014;40:1361\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"3328_CR16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.5483\/BMBRep.2019.52.12.249","volume":"52","author":"SH Park","year":"2019","unstructured":"Park SH, Lee AR, Choi K, Joung S, Yoon JB, Kim S. TOMM20 as a potential therapeutic target of colorectal cancer. BMB Rep. 2019;52:712\u20137.","journal-title":"BMB Rep"},{"key":"3328_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165962","volume":"1866","author":"ME Roche","year":"2020","unstructured":"Roche ME, Lin Z, Whitaker-Menezes D, Zhan T, Szuhai K, Bovee J, et al. Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165962.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3328_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2021.104620","volume":"120","author":"X Yang","year":"2021","unstructured":"Yang X, Song D, Zhang J, Yang X, Feng H, Guo J. PRR34-AS1 sponges miR-498 to facilitate TOMM20 and ITGA6 mediated tumor progression in HCC. Exp Mol Pathol. 2021;120:104620.","journal-title":"Exp Mol Pathol"},{"key":"3328_CR19","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/pros.21021","volume":"69","author":"MH Levesque","year":"2009","unstructured":"Levesque MH, El-Alfy M, Cusan L, Labrie F. Androgen receptor as a potential sign of prostate cancer metastasis. Prostate. 2009;69:1704\u201311.","journal-title":"Prostate"},{"key":"3328_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-023-02776-0","volume":"42","author":"L Yin","year":"2023","unstructured":"Yin L, Ye Y, Zou L, Lin J, Dai Y, Fu Y, et al. AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer. J Exp Clin Cancer Res. 2023;42:204.","journal-title":"J Exp Clin Cancer Res"},{"key":"3328_CR21","unstructured":"Li B, Lu W, Chen Z. Regulation of androgen receptor by E3 ubiquitin ligases: for more or less. Receptors Clin Investig. 2014;1:10."},{"key":"3328_CR22","doi-asserted-by":"crossref","unstructured":"Ratajczak W, Lubkowski M, Lubkowska A. Heat shock proteins in benign prostatic hyperplasia and prostate cancer. Int J Mol Sci. 2022;23:897.","DOI":"10.3390\/ijms23020897"},{"key":"3328_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11594-y","volume":"10","author":"B Eftekharzadeh","year":"2019","unstructured":"Eftekharzadeh B, Banduseela VC, Chiesa G, Martinez-Cristobal P, Rauch JN, Nath SR, et al. Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor. Nat Commun. 2019;10:3562.","journal-title":"Nat Commun"},{"key":"3328_CR24","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1021\/bi980746y","volume":"37","author":"E Schleiff","year":"1998","unstructured":"Schleiff E, Turnbull JL. Characterization of the N-terminal targeting signal binding domain of the mitochondrial outer membrane receptor, Tom20. Biochemistry. 1998;37:13052\u20138.","journal-title":"Biochemistry"},{"key":"3328_CR25","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","volume":"28","author":"B Zhou","year":"2018","unstructured":"Zhou B, Zhang JY, Liu XS, Chen HZ, Ai YL, Cheng K, et al. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Res. 2018;28:1171\u201385.","journal-title":"Cell Res"},{"key":"3328_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03471-8","volume":"12","author":"L Lalier","year":"2021","unstructured":"Lalier L, Mignard V, Joalland MP, Lanoe D, Cartron PF, Manon S, et al. TOM20-mediated transfer of Bcl2 from ER to MAM and mitochondria upon induction of apoptosis. Cell Death Dis. 2021;12:182.","journal-title":"Cell Death Dis"},{"key":"3328_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101671","volume":"36","author":"ZJ Fu","year":"2020","unstructured":"Fu ZJ, Wang ZY, Xu L, Chen XH, Li XX, Liao WT, et al. HIF-1alpha-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia\/reperfusion injury. Redox Biol. 2020;36:101671.","journal-title":"Redox Biol"},{"key":"3328_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jcb.20228","volume":"93","author":"J Kim","year":"2004","unstructured":"Kim J, Coetzee GA. Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem. 2004;93:233\u201341.","journal-title":"J Cell Biochem"},{"key":"3328_CR29","doi-asserted-by":"publisher","first-page":"20180077","DOI":"10.1098\/rsfs.2018.0077","volume":"9","author":"J Tkac","year":"2019","unstructured":"Tkac J, Gajdosova V, Hroncekova S, Bertok T, Hires M, Jane E, et al. Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer. Interface Focus. 2019;9:20180077.","journal-title":"Interface Focus"},{"key":"3328_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0093-7754(03)00346-4","volume":"30","author":"DB Solit","year":"2003","unstructured":"Solit DB, Scher HI, Rosen N. Hsp90 as a therapeutic target in prostate cancer. Semin Oncol. 2003;30:709\u201316.","journal-title":"Semin Oncol"},{"key":"3328_CR31","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1158\/1535-7163.MCT-16-0241","volume":"15","author":"L Chen","year":"2016","unstructured":"Chen L, Li J, Farah E, Sarkar S, Ahmad N, Gupta S, et al. Cotargeting HSP90 and its client proteins for treatment of prostate cancer. Mol Cancer Ther. 2016;15:2107\u201318.","journal-title":"Mol Cancer Ther"},{"key":"3328_CR32","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1158\/0008-5472.CAN-17-3728","volume":"78","author":"MA Moses","year":"2018","unstructured":"Moses MA, Kim YS, Rivera-Marquez GM, Oshima N, Watson MJ, Beebe KE, et al. Targeting the Hsp40\/Hsp70 chaperone axis as a novel strategy to treat castration-resistant prostate cancer. Cancer Res. 2018;78:4022\u201335.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03328-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:40:32Z","timestamp":1747820432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03328-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":32,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,6,11]]}},"alternative-id":["3328"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03328-w","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}